07:10:27 EDT Tue 29 Sep 2020
Enter Symbol
or Name

Login ID:
Trillium Therapeutics Inc (2)
Symbol TRIL
Shares Issued 28,038,831
Close 2019-09-03 C$ 0.38
Recent Sedar Documents

Trillium to present at investor conference Sept. 10

2019-09-05 09:03 ET - News Release

Mr. James Parsons reports

Trillium Therapeutics To Present At Investor Conference

Trillium Therapeutics Inc. is scheduled to present at the following upcoming investor conference.

H.C. Wainwright 21st Annual Global Investment Conference

Presenter:  Dr. Bob Uger, chief scientific officer and interim president

Date and time:  Sept. 10, 2019, at 4:40 p.m. ET

Location:  Lotte New York Palace Hotel, New York

A live audio webcast of the H.C. Wainwright 21st Annual Global Investment Conference presentation will be available under the investor relations section of Trillium's website.

About Trillium Therapeutics Inc.

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer.

© 2020 Canjex Publishing Ltd. All rights reserved.